BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22791413)

  • 1. The effects of 17β-estradiol plus drospirenone on anthropometric and biochemical measures of adiposity in menopausal women.
    Karakus M; Gelisgen R; Topcuoglu A; Guralp O; Topcuoglu D; Simsek G; Uludag S; Uzun H
    Arch Gynecol Obstet; 2012 Nov; 286(5):1233-9. PubMed ID: 22791413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
    Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
    Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 17beta-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women.
    Tankó LB; Christiansen C
    J Intern Med; 2005 Dec; 258(6):544-53. PubMed ID: 16313478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
    Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
    Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women.
    Castracane VD; Kraemer GR; Ogden BW; Kraemer RR
    Maturitas; 2006 Jan; 53(2):217-25. PubMed ID: 15913927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables.
    Jürimäe J; Jürimäe T
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E42-7. PubMed ID: 17341545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC
    Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
    Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
    Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bilateral ovariectomy and estrogen replacement therapy on serum leptin, sex hormone binding globulin and insulin like growth factor-I levels.
    Nar A; Demirtas E; Ayhan A; Gurlek A
    Gynecol Endocrinol; 2009 Dec; 25(12):773-8. PubMed ID: 19905995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
    Casanova G; Radavelli S; Lhullier F; Spritzer PM
    Fertil Steril; 2009 Aug; 92(2):605-12. PubMed ID: 18706557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
    Cakiroglu Y; Vural B; Isgoren S
    Arch Gynecol Obstet; 2013 Jul; 288(1):213-20. PubMed ID: 23377194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
    Sağsöz N; Orbak Z; Noyan V; Yücel A; Uçar B; Yildiz L
    Fertil Steril; 2009 Aug; 92(2):660-6. PubMed ID: 18973889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
    Dedeoğlu EN; Erenus M; Yörük P
    Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women.
    Kunnari A; Santaniemi M; Jokela M; Karjalainen AH; Heikkinen J; Ukkola O; Kesäniemi YA
    Metabolism; 2008 Nov; 57(11):1509-15. PubMed ID: 18940387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks.
    Gupta P; Harte A; Sturdee DW; Sharma A; Barnett AH; Kumar S; McTernan PG
    Climacteric; 2008 Oct; 11(5):364-72. PubMed ID: 18781480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.